Kirkland & Ellis advised global alternative asset management firm TPG on a majority investment in Surescripts, the nation’s leading health information network. The transaction was announced October 1, 2024. TPG is investing in Surescripts through TPG Capital, the firm’s U.S. and European private equity platform. The investment will allow Surescripts to develop an array of solutions addressing healthcare’s biggest challenges and accelerate Surescripts’ ability to scale existing Intelligent Prescribing, Benefits and Authorizations, and Clinical Interoperability solutions. The transaction is subject to customary regulatory approvals. Read the transaction press release The Kirkland team was led by corporate partners Michael Weisser, Maggie Flores and Zach Miller; antitrust & competition partner Matt Reilly; tax partners Jared Rusman and Bill Dong; executive compensation partners Stephen Jacobson and Alison Beskin; and technology & IP transactions partners Seth Traxler and Shellie Freedman.